Li WF - Search Results

1

Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma.

Peng H, Dong D, Fang MJ, Li L, Tang LL, Chen L, Li WF, Mao YP, Fan W, Liu LZ, Tian L, Lin AH, Sun Y, Tian J, Ma J. Peng H, et al. Among authors: li wf, li l. Clin Cancer Res. 2019 Jul 15;25(14):4271-4279. doi: 10.1158/1078-0432.CCR-18-3065. Epub 2019 Apr 11. Clin Cancer Res. 2019. PMID: 30975664

2

[A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma].

Mao YP, Li WF, Chen L, Sun Y, Liu LZ, Tang LL, Cao SM, Lin AH, Hong MH, Lu TX, Liu MZ, Li L, Ma J. Mao YP, et al. Among authors: li wf, li l. Ai Zheng. 2009 Oct;28(10):1022-8. doi: 10.5732/cjc.009.10425. Ai Zheng. 2009. PMID: 19799808 Free article. Chinese.

3

How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?

Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, Sun Y, Lin AH, Liu MZ, Ma J. Lai SZ, et al. Among authors: li wf. Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):661-8. doi: 10.1016/j.ijrobp.2010.03.024. Epub 2010 Jul 17. Int J Radiat Oncol Biol Phys. 2011. PMID: 20643517

4

Prognostic value and staging categories of anatomic masticator space involvement in nasopharyngeal carcinoma: a study of 924 cases with MR imaging.

Tang LL, Li WF, Chen L, Sun Y, Chen Y, Liu LZ, Mao YP, Lin AH, Li L, Ma J. Tang LL, et al. Among authors: li wf, li l. Radiology. 2010 Oct;257(1):151-7. doi: 10.1148/radiol.10100033. Epub 2010 Aug 9. Radiology. 2010. PMID: 20697119

5

Prognostic value of prevertebral space involvement in nasopharyngeal carcinoma based on intensity-modulated radiotherapy.

Zhou GQ, Mao YP, Chen L, Li WF, Liu LZ, Sun Y, Chen Y, Tian L, Lin AH, Li L, Ma J. Zhou GQ, et al. Among authors: li wf, li l. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1090-7. doi: 10.1016/j.ijrobp.2010.11.063. Epub 2011 Aug 22. Int J Radiat Oncol Biol Phys. 2012. PMID: 21864993

6

Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.

Zhou GQ, Tang LL, Mao YP, Chen L, Li WF, Sun Y, Liu LZ, Li L, Lin AH, Ma J. Zhou GQ, et al. Among authors: li wf, li l. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e359-65. doi: 10.1016/j.ijrobp.2011.06.1967. Epub 2011 Oct 12. Int J Radiat Oncol Biol Phys. 2012. PMID: 22000748

7

Prognostic value of subclassification using MRI in the t4 classification nasopharyngeal carcinoma intensity-modulated radiotherapy treatment.

Chen L, Liu LZ, Chen M, Li WF, Yin WJ, Lin AH, Sun Y, Li L, Ma J. Chen L, et al. Among authors: li wf, li l. Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):196-202. doi: 10.1016/j.ijrobp.2011.11.021. Epub 2012 Jan 31. Int J Radiat Oncol Biol Phys. 2012. PMID: 22300569

8

Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.

Sun Y, Tang LL, Chen L, Li WF, Mao YP, Liu LZ, Lin AH, Li L, Ma J. Sun Y, et al. Among authors: li wf, li l. BMC Cancer. 2012 Feb 15;12:68. doi: 10.1186/1471-2407-12-68. BMC Cancer. 2012. PMID: 22336097 Free PMC article.

9

Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma.

Li WF, Liu N, Cui RX, He QM, Chen M, Jiang N, Sun Y, Zeng J, Liu LZ, Ma J. Li WF, et al. J Transl Med. 2012 Apr 26;10:78. doi: 10.1186/1479-5876-10-78. J Transl Med. 2012. PMID: 22537306 Free PMC article.

10

Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.

Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei RR, Zhang MY, Sun Y, Huang BJ, Chen M, He QM, Jiang N, Chen L, Cho WC, Yun JP, Zeng J, Liu LZ, Li L, Guo Y, Wang HY, Ma J. Liu N, et al. Among authors: li wf, li y, li l. Lancet Oncol. 2012 Jun;13(6):633-41. doi: 10.1016/S1470-2045(12)70102-X. Epub 2012 May 3. Lancet Oncol. 2012. PMID: 22560814

11

Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation.

Li WF, Sun Y, Chen M, Tang LL, Liu LZ, Mao YP, Chen L, Zhou GQ, Li L, Ma J. Li WF, et al. Among authors: li l. Chin J Cancer. 2012 Dec;31(12):579-87. doi: 10.5732/cjc.012.10095. Epub 2012 Aug 2. Chin J Cancer. 2012. PMID: 22854064 Free PMC article.

12

Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival.

Cui RX, Liu N, He QM, Li WF, Huang BJ, Sun Y, Tang LL, Chen M, Jiang N, Chen L, Yun JP, Zeng J, Guo Y, Wang HY, Ma J. Cui RX, et al. Among authors: li wf. BMC Cancer. 2012 Aug 29;12:376. doi: 10.1186/1471-2407-12-376. BMC Cancer. 2012. PMID: 22931099 Free PMC article.

13

Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?

Guo R, Sun Y, Yu XL, Yin WJ, Li WF, Chen YY, Mao YP, Liu LZ, Li L, Lin AH, Ma J. Guo R, et al. Among authors: li wf, li l. Radiother Oncol. 2012 Sep;104(3):294-9. doi: 10.1016/j.radonc.2012.09.001. Epub 2012 Sep 19. Radiother Oncol. 2012. PMID: 22998947

14

Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.

Li WF, Sun Y, Mao YP, Chen L, Chen YY, Chen M, Liu LZ, Lin AH, Li L, Ma J. Li WF, et al. Among authors: li l. Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):249-56. doi: 10.1016/j.ijrobp.2012.09.003. Epub 2012 Nov 29. Int J Radiat Oncol Biol Phys. 2013. PMID: 23200171

15

Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China.

Chen Y, Sun Y, Liang SB, Zong JF, Li WF, Chen M, Chen L, Mao YP, Tang LL, Guo Y, Lin AH, Liu MZ, Ma J. Chen Y, et al. Among authors: li wf. Cancer. 2013 Jun 15;119(12):2230-8. doi: 10.1002/cncr.28049. Epub 2013 Apr 10. Cancer. 2013. PMID: 23576020 Free article. Clinical Trial.

16

Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity-modulated radiotherapy.

Chen M, Tang LL, Sun Y, Mao YP, Li WF, Guo R, Liu LZ, Li L, Lin AH, Ma J. Chen M, et al. Among authors: li wf, li l. Head Neck. 2014 Apr;36(4):468-73. doi: 10.1002/hed.23314. Epub 2013 Jun 18. Head Neck. 2014. PMID: 23780916

17

Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.

Tao CJ, Liu X, Tang LL, Mao YP, Chen L, Li WF, Yu XL, Liu LZ, Zhang R, Lin AH, Ma J, Sun Y. Tao CJ, et al. Among authors: li wf. Chin J Cancer. 2013 Sep;32(9):494-501. doi: 10.5732/cjc.013.10121. Epub 2013 Aug 28. Chin J Cancer. 2013. PMID: 23981849 Free PMC article.

18

Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma.

Tao CJ, Liu X, Tang LL, Mao YP, Chen L, Li WF, Yu XL, Liu LZ, Zhang R, Lin AH, Ma J, Sun Y. Tao CJ, et al. Among authors: li wf. Chin J Cancer. 2013 Oct;32(10):525-32. doi: 10.5732/cjc.013.10124. Epub 2013 Sep 10. Chin J Cancer. 2013. PMID: 24016394 Free PMC article.

19

Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China.

Liu X, Li X, Jiang N, Lei Y, Tang LL, Chen L, Zhou GQ, Sun Y, Yue D, Guo R, Mao YP, Li WF, Liu LZ, Tian L, Lin AH, Ma J. Liu X, et al. Among authors: li wf, li x. Cancer. 2014 Jan 1;120(1):68-76. doi: 10.1002/cncr.28377. Epub 2013 Sep 24. Cancer. 2014. PMID: 24114075 Free article.

20

Prognostic value of parapharyngeal extension in nasopharyngeal carcinoma treated with intensity modulated radiotherapy.

Tang LL, Sun Y, Mao YP, Chen Y, Li WF, Chen L, Liu LZ, Lin AH, Li L, Ma J. Tang LL, et al. Among authors: li wf, li l. Radiother Oncol. 2014 Mar;110(3):404-8. doi: 10.1016/j.radonc.2013.10.007. Epub 2013 Oct 30. Radiother Oncol. 2014. PMID: 24183063

21

Hotspot mutations in common oncogenes are infrequent in nasopharyngeal carcinoma.

Jiang N, Liu N, Yang F, Zhou Q, Cui R, Jiang W, He Q, Li W, Guo Y, Zeng J, Yun J, Chen X, Zhou B, Sun Y, Wang H, Chen ZG, Ma J. Jiang N, et al. Oncol Rep. 2014 Oct;32(4):1661-9. doi: 10.3892/or.2014.3376. Epub 2014 Aug 1. Oncol Rep. 2014. PMID: 25109408

22

Is replacement of the supraclavicular fossa with the lower level classification based on magnetic resonance imaging beneficial in nasopharyngeal carcinoma?

Yue D, Xu YF, Zhang F, Lin L, Mao YP, Li WF, Chen L, Sun Y, Liu LZ, Lin AH, Li L, Ma J. Yue D, et al. Among authors: li wf, li l. Radiother Oncol. 2014 Oct;113(1):108-14. doi: 10.1016/j.radonc.2014.08.036. Epub 2014 Sep 19. Radiother Oncol. 2014. PMID: 25245557

23

Comorbidity predicts poor prognosis in nasopharyngeal carcinoma: development and validation of a predictive score model.

Guo R, Chen XZ, Chen L, Jiang F, Tang LL, Mao YP, Zhou GQ, Li WF, Liu LZ, Tian L, Lin AH, Ma J. Guo R, et al. Among authors: li wf. Radiother Oncol. 2015 Feb;114(2):249-56. doi: 10.1016/j.radonc.2014.12.002. Epub 2015 Jan 21. Radiother Oncol. 2015. PMID: 25618213

24

Prognostic value of MET protein overexpression and gene amplification in locoregionally advanced nasopharyngeal carcinoma.

Li Y, Li W, He Q, Xu Y, Ren X, Tang X, Wen X, Yang X, Sun Y, Zeng J, Yun J, Liu N, Ma J. Li Y, et al. Oncotarget. 2015 May 30;6(15):13309-19. doi: 10.18632/oncotarget.3751. Oncotarget. 2015. PMID: 25965822 Free PMC article.

25

The clinical utility of plasma Epstein-Barr virus DNA assays in nasopharyngeal carcinoma: the dawn of a new era?: a systematic review and meta-analysis of 7836 cases.

Zhang W, Chen Y, Chen L, Guo R, Zhou G, Tang L, Mao Y, Li W, Liu X, Du X, Sun Y, Ma J. Zhang W, et al. Medicine (Baltimore). 2015 May;94(20):e845. doi: 10.1097/MD.0000000000000845. Medicine (Baltimore). 2015. PMID: 25997061 Free PMC article. Review.

26

Prognostic value of the primary lesion apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma: a retrospective study of 541 cases.

Zhang Y, Liu X, Zhang Y, Li WF, Chen L, Mao YP, Shen JX, Zhang F, Peng H, Liu Q, Sun Y, Ma J. Zhang Y, et al. Among authors: li wf. Sci Rep. 2015 Jul 17;5:12242. doi: 10.1038/srep12242. Sci Rep. 2015. PMID: 26184509 Free PMC article.

27

Potential surrogate endpoints for overall survival in locoregionally advanced nasopharyngeal carcinoma: an analysis of a phase III randomized trial.

Chen YP, Chen Y, Zhang WN, Liang SB, Zong JF, Chen L, Mao YP, Tang LL, Li WF, Liu X, Guo Y, Lin AH, Liu MZ, Sun Y, Ma J. Chen YP, et al. Among authors: li wf. Sci Rep. 2015 Jul 29;5:12502. doi: 10.1038/srep12502. Sci Rep. 2015. PMID: 26219568 Free PMC article.

28

Surrogate endpoints for overall survival in combined chemotherapy and radiotherapy trials in nasopharyngeal carcinoma: Meta-analysis of randomised controlled trials.

Chen YP, Sun Y, Chen L, Mao YP, Tang LL, Li WF, Liu X, Zhang WN, Zhou GQ, Guo R, Lin AH, Ma J. Chen YP, et al. Among authors: li wf. Radiother Oncol. 2015 Aug;116(2):157-66. doi: 10.1016/j.radonc.2015.07.030. Epub 2015 Aug 1. Radiother Oncol. 2015. PMID: 26243677 Review.

29

Comparison of the treatment outcomes of intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in nasopharyngeal carcinoma patients with parapharyngeal space extension.

Tang LL, Chen L, Mao YP, Li WF, Sun Y, Liu LZ, Lin AH, Mai HQ, Shao JY, Li L, Ma J. Tang LL, et al. Among authors: li wf, li l. Radiother Oncol. 2015 Aug;116(2):167-73. doi: 10.1016/j.radonc.2015.07.038. Epub 2015 Aug 24. Radiother Oncol. 2015. PMID: 26316395

30

Effect of latent membrane protein 1 expression on overall survival in Epstein-Barr virus-associated cancers: a literature-based meta-analysis.

Chen YP, Zhang WN, Chen L, Tang LL, Mao YP, Li WF, Liu X, Zhou GQ, Sun Y, Kang TB, Zeng MS, Liu N, Ma J. Chen YP, et al. Among authors: li wf. Oncotarget. 2015 Oct 6;6(30):29311-23. doi: 10.18632/oncotarget.4906. Oncotarget. 2015. PMID: 26336130 Free PMC article. Review.

31

Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.

Zhang Y, Li WF, Chen L, Mao YP, Guo R, Zhang F, Peng H, Liu LZ, Li L, Liu Q, Ma J. Zhang Y, et al. Among authors: li wf, li l. Sci Rep. 2015 Sep 8;5:13919. doi: 10.1038/srep13919. Sci Rep. 2015. PMID: 26345410 Free PMC article.

32

Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis.

Zhang F, Cheng YK, Li WF, Guo R, Chen L, Sun Y, Mao YP, Zhou GQ, Liu X, Liu LZ, Lin AH, Tang LL, Ma J. Zhang F, et al. Among authors: li wf. BMC Cancer. 2015 Oct 15;15:709. doi: 10.1186/s12885-015-1669-z. BMC Cancer. 2015. PMID: 26472233 Free PMC article.

33

Propensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.

Li WF, Li YQ, Chen L, Zhang Y, Guo R, Zhang F, Peng H, Sun Y, Ma J. Li WF, et al. Among authors: li yq. BMC Cancer. 2015 Oct 27;15:810. doi: 10.1186/s12885-015-1768-x. BMC Cancer. 2015. PMID: 26506820 Free PMC article.

34

Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy.

Chen YP, Tang LL, Zhang WN, Mao YP, Chen L, Sun Y, Liu LZ, Li WF, Liu X, Zhou GQ, Guo R, Mai HQ, Shao JY, Lin AH, Li L, Ma J. Chen YP, et al. Among authors: li wf, li l. Medicine (Baltimore). 2015 Oct;94(43):e1624. doi: 10.1097/MD.0000000000001624. Medicine (Baltimore). 2015. PMID: 26512556 Free PMC article.

35

Efficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis.

Zhang F, Zhang Y, Li WF, Liu X, Guo R, Sun Y, Lin AH, Chen L, Ma J. Zhang F, et al. Among authors: li wf. Sci Rep. 2015 Nov 27;5:17378. doi: 10.1038/srep17378. Sci Rep. 2015. PMID: 26611462 Free PMC article.

36

Risk stratification based on change in plasma Epstein-Barr virus DNA load after treatment in nasopharyngeal carcinoma.

Zhang Y, Li WF, Mao YP, Guo R, Tang LL, Peng H, Sun Y, Liu Q, Chen L, Ma J. Zhang Y, et al. Among authors: li wf. Oncotarget. 2016 Feb 23;7(8):9576-85. doi: 10.18632/oncotarget.7083. Oncotarget. 2016. PMID: 26840023 Free PMC article.

37

Corrigendum: Efficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis.

Zhang F, Zhang Y, Li WF, Liu X, Guo R, Sun Y, Lin AH, Chen L, Ma J. Zhang F, et al. Among authors: li wf. Sci Rep. 2016 Feb 8;6:20748. doi: 10.1038/srep20748. Sci Rep. 2016. PMID: 26855358 Free PMC article. No abstract available.

38

Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.

Zhang Y, Li WF, Mao YP, Zhou GQ, Peng H, Sun Y, Liu Q, Chen L, Ma J. Zhang Y, et al. Among authors: li wf. Oncotarget. 2016 Mar 22;7(12):13612-20. doi: 10.18632/oncotarget.7253. Oncotarget. 2016. PMID: 26871291 Free PMC article.

39

Cigarette smoking complements the prognostic value of baseline plasma Epstein-Barr virus deoxyribonucleic acid in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy: a large-scale retrospective cohort study.

Lv JW, Chen YP, Zhou GQ, Tang LL, Mao YP, Li WF, Guo R, Lin AH, Ma J, Sun Y. Lv JW, et al. Among authors: li wf. Oncotarget. 2016 Mar 29;7(13):16806-17. doi: 10.18632/oncotarget.7609. Oncotarget. 2016. PMID: 26919237 Free PMC article.

40

Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation Therapy.

Peng H, Guo R, Chen L, Zhang Y, Li WF, Mao YP, Sun Y, Zhang F, Liu LZ, Lin AH, Ma J. Peng H, et al. Among authors: li wf. Sci Rep. 2016 Feb 29;6:22000. doi: 10.1038/srep22000. Sci Rep. 2016. PMID: 26924234 Free PMC article.

41

Prognostic value of Diabetes in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy.

Peng H, Chen L, Zhang Y, Li WF, Mao YP, Zhang F, Guo R, Liu LZ, Lin AH, Sun Y, Ma J. Peng H, et al. Among authors: li wf. Sci Rep. 2016 Mar 1;6:22200. doi: 10.1038/srep22200. Sci Rep. 2016. PMID: 26927312 Free PMC article.

42

Primary tumor inflammation in gross tumor volume as a prognostic factor for nasopharyngeal carcinoma patients.

Peng H, Chen L, Tang LL, Zhang Y, Li WF, Mao YP, Zhang F, Guo R, Liu LZ, Tian L, Lin AH, Sun Y, Ma J. Peng H, et al. Among authors: li wf. Oncotarget. 2016 Mar 22;7(12):14963-72. doi: 10.18632/oncotarget.7699. Oncotarget. 2016. PMID: 26934649 Free PMC article.

43

Prognostic value of wait time in nasopharyngeal carcinoma treated with intensity modulated radiotherapy: a propensity matched analysis.

Chen YP, Mao YP, Zhang WN, Chen L, Tang LL, Li WF, Liu X, Zhou GQ, Guo R, Sun Y, Kang TB, Zeng MS, Ma J. Chen YP, et al. Among authors: li wf. Oncotarget. 2016 Mar 22;7(12):14973-82. doi: 10.18632/oncotarget.7789. Oncotarget. 2016. PMID: 26942870 Free PMC article.

44

Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.

Peng H, Chen L, Zhang Y, Guo R, Li WF, Mao YP, Tan LL, Sun Y, Zhang F, Liu LZ, Tian L, Lin AH, Ma J. Peng H, et al. Among authors: li wf. Oncotarget. 2016 Apr 26;7(17):24208-16. doi: 10.18632/oncotarget.8144. Oncotarget. 2016. PMID: 27008701 Free PMC article.

45

The Cumulative Cisplatin Dose Affects the Long-Term Survival Outcomes of Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy.

Peng H, Chen L, Li WF, Guo R, Mao YP, Zhang Y, Zhang F, Liu LZ, Tian L, Lin AH, Sun Y, Ma J. Peng H, et al. Among authors: li wf. Sci Rep. 2016 Apr 13;6:24332. doi: 10.1038/srep24332. Sci Rep. 2016. PMID: 27071833 Free PMC article.

46

The Tumour Response to Induction Chemotherapy has Prognostic Value for Long-Term Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.

Peng H, Chen L, Zhang Y, Li WF, Mao YP, Liu X, Zhang F, Guo R, Liu LZ, Tian L, Lin AH, Sun Y, Ma J. Peng H, et al. Among authors: li wf. Sci Rep. 2016 Apr 21;6:24835. doi: 10.1038/srep24835. Sci Rep. 2016. PMID: 27099096 Free PMC article.

47

Should All Nasopharyngeal Carcinoma with Paranasal Sinus Invasion Be Staged as T3 in the Intensity-Modulated Radiotherapy Era? A Study of 1811 Cases.

Zhang Y, Peng H, Guo R, Li WF, Chen L, Liu X, Tang LL, Liu LZ, Li L, Liu Q, Sun Y, Ma J. Zhang Y, et al. Among authors: li wf, li l. J Cancer. 2016 Jun 28;7(10):1353-9. doi: 10.7150/jca.15141. eCollection 2016. J Cancer. 2016. PMID: 27390611 Free PMC article.

48

Exploration and Validation of C-Reactive Protein/Albumin Ratio as a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma.

Zhang Y, Zhou GQ, Liu X, Chen L, Li WF, Tang LL, Liu Q, Sun Y, Ma J. Zhang Y, et al. Among authors: li wf. J Cancer. 2016 Jul 4;7(11):1406-12. doi: 10.7150/jca.15401. eCollection 2016. J Cancer. 2016. PMID: 27471556 Free PMC article.

49

Prognostic Value of Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma with Low Pre-treatment Epstein-Barr Virus DNA: a Propensity-matched Analysis.

Peng H, Chen L, Li WF, Guo R, Zhang Y, Zhang F, Liu LZ, Tian L, Lin AH, Sun Y, Ma J. Peng H, et al. Among authors: li wf. J Cancer. 2016 Jul 5;7(11):1465-71. doi: 10.7150/jca.15736. eCollection 2016. J Cancer. 2016. PMID: 27471562 Free PMC article.

50

Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial.

Peng H, Chen L, Zhang Y, Li WF, Mao YP, Zhang F, Guo R, Liu LZ, Lin AH, Sun Y, Ma J. Peng H, et al. Among authors: li wf. Oncologist. 2016 Nov;21(11):1369-1376. doi: 10.1634/theoncologist.2016-0105. Epub 2016 Aug 5. Oncologist. 2016. PMID: 27496040 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

612 results

Search Page